Immunoregulatory Effect of Ginsenoside Rd against $CD4^+$ Th lymphocyte

인삼배당체 Rd의 $CD4^+$ Th 임파구에 대한 면역조절효과

  • Joo, Inkyung (Department of ImmunoMicrobiology, College of Pharmacy, Dongduk Women's University) ;
  • Kim, Jeonghyeon (Department of ImmunoMicrobiology, College of Pharmacy, Dongduk Women's University) ;
  • Shehzad, Omer (Natural Products Research Institute, College of Pharmacy, Seoul National University) ;
  • Kim, Yeong Shik (Natural Products Research Institute, College of Pharmacy, Seoul National University) ;
  • Han, Yongmoon (Department of ImmunoMicrobiology, College of Pharmacy, Dongduk Women's University)
  • 주인경 (동덕여자대학교 약학대학 면역.미생물학교실) ;
  • 김정현 (동덕여자대학교 약학대학 면역.미생물학교실) ;
  • 오마 쉐자드 (서울대학교 약학대학 천연물연구소) ;
  • 김영식 (서울대학교 약학대학 천연물연구소) ;
  • 한용문 (동덕여자대학교 약학대학 면역.미생물학교실)
  • Received : 2013.01.04
  • Accepted : 2013.02.25
  • Published : 2013.02.28

Abstract

In this present study, we determined the immunoregulatory activity of ginsenoside Rd extract from Panax ginseng. To determine the activity, we tested Rd against $CD4^+$ Th cells in a murine model of type 1 diabetes, which involves Th1-dominant immunity. The type 1 diabetes was caused by streptozotocin (STZ) and the severity of the diabetes was evaluated by measuring the degree of hyperglycemia, a major symptom of diabetes. The data resulting from experiments showed that ginsenoside Rd induced a greater level of Th1 type cytokines [IFN-${\gamma}$ & IL-2] than Th2 type [IL-4 & IL-10] (P<0.05), which was determined by cytokine profile analysis. In the animal model of diabetes, the depletion of $CD4^+$ Th cells by a treatment of anti-CD4 mAb resulted in considerably lower values of blood-glucose levels than those of the mAb-untreated mice, which indicates that the Th1 immune response from $CD4^+$ Th cells are responsible for diabetes. Based on these observations, the effect of Rd on diabetes was examined in the same animal model. Results showed that Rd-treated mice groups had increased levels of blood glucose compared to Rd-untreated mice groups that were used as a negative control (P<0.05). In other words, Rd aggravated the diabetes via the Th1 immune response. In conclusion, ginsenoside Rd had an immunoregulatory activity of Th1-dominant immunity.

Keywords

References

  1. Nakayamada, S., Takahashi, H., Kanno, Y. and O'Shea, J. J. : Helper T cell diversity and plasticity. Curr. Opin. Immunol. 24, 297 (2012). https://doi.org/10.1016/j.coi.2012.01.014
  2. Mosmann, T. R., Cherwinski, H., Bond, M. W., et al. : Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348 (1986).
  3. Parris, K. : Th1/Th2 Balance: The Hypothesis, its Limitations, and Implications for Health and Disease. Alternative Medicine Review 8, 3 (2003).
  4. Yoon, J.-W. and Jun, H.-S. : Autoimmune Destruction of Pancreatic $\beta$ cells American Journal of Therapeutics 12, 580 (2005). https://doi.org/10.1097/01.mjt.0000178767.67857.63
  5. Bhagirath Singh, Enayat Nikoopour, Katrina Huszarik, John F. Elliott and Anthony M. Jevnikar : Immunomodulation and regeneration of islet beta cells by cytokines in autoimmune type 1 diabetes. Journal of Interferon & Cytokine Research 31, 10 (2011).
  6. Lee, M.-S. and Kim, K.-A. : Type 1 diabetes mellitus. J. Korean Med. Assoc. 52, 677 (2009). https://doi.org/10.5124/jkma.2009.52.7.677
  7. Abi Khalil, C., Roussel, R., Mohammedi, K., Danchin, N. and Marre, M. : Cause-specific mortality in diabetes: recent changes in trend mortality. Eur. J. Prev. Cardiol. 19, 374 (2012). https://doi.org/10.1177/1741826711409324
  8. Johnson, P. R. and Jones, K. E. : Pancreatic islet transplantation. Semin. Pediatr. Surg. 21, 272 (2012). https://doi.org/10.1053/j.sempedsurg.2012.05.012
  9. Noguchi, H. : Pancreatic islet transplantation. World J. Gastrointest Surg. 1, 16 (2009). https://doi.org/10.4240/wjgs.v1.i1.16
  10. Corbett, J. A. : K cells: a novel target for insulin gene therapy for the prevention of diabetes. Trends Endocrinol. Metab. 12, 140 (2001). https://doi.org/10.1016/S1043-2760(01)00400-3
  11. Encina, G., Ezquer, F., Conget, P. and Israel, Y. : Insulin is secreted upon glucose stimulation by both gastrointestinal enteroendocrine K-cells and L-cells engineered with the preproinsulin gene. Biol. Res. 44, 301 (2011). https://doi.org/10.4067/S0716-97602011000300012
  12. Sanlioglu, A. D., Altunbas, H. A., Balci, M. K., Griffith, T. S. and Sanlioglu, S. : Insulin gene therapy from design to beta cell generation. Expert. Rev. Mol. Med. 10, 1017 (2012).
  13. Dominguez-Bendala, J., Lanzoni, G., Inverardi, L. and Ricordi, C. : Concise review: mesenchymal stem cells for diabetes. Stem. Cells Transl. Med. 1, 59 (2012). https://doi.org/10.5966/sctm.2011-0017
  14. Li, L., Gu, W. and Zhu, D. : Novel therapy for type 1 diabetes: Autologous hematopoietic stem cell transplantation. J. Diabetes. 4, 332 (2012). https://doi.org/10.1111/jdb.12002
  15. Hsin-Yi Hung, Keduo Qian, Susan L. Morris-Natschke, Chau-Shin Hsu and Kuo-Hsiung Lee : Recent discovery of plant-derived anti-diabetic natural products Nat. Prod. Rep. 29, 580 (2012). https://doi.org/10.1039/c2np00074a
  16. Geetha, G., Kalavalarasariel Gopinathapillai, P. and Sankar, V. : Anti diabetic effect of Achyranthes rubrofusca leaf extracts on alloxan induced diabetic rats. Pak. J. Pharm. Sci. 24, 193 (2011).
  17. Shen, Y., Fukushima, M., Ito, Y., Muraki, E., Hosono, T., Seki, T. and Ariga, T. : Verification of the antidiabetic effects of cinnamon (Cinnamomum zeylanicum) using insulin-uncontrolled type 1 diabetic rats and cultured adipocytes. Biosci. Biotechnol. Biochem. 74, 2418 (2010). https://doi.org/10.1271/bbb.100453
  18. Shibata, S. : Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J. Korean Med. Sci. Suppl, S28 (2001).
  19. Hong, Y. J., Kim, N., Lee, K., Hee Sonn, C., Eun Lee, J., Tae Kim, S., Ho Baeg, I. and Lee, K. M. : Korean red ginseng (Panax ginseng) ameliorates type1 diabetes and restores immune cell compartments. Journal of Ethnopharmacology 144, 225 (2012). https://doi.org/10.1016/j.jep.2012.08.009
  20. Park, M. J., Bae, C. S., Lim, S. K., Kim, D. I., Lim, J. C., Kim, J. C., Han, H. J., Moon, J. H., Kim, K. Y., Yoon, K.-C. and Park, S. H. : Effect of protopanaxadiol derivatives in high glucoseinduced fibronectin expression in primary cultured rat mesangial cells: Role of mitogen-activated protein kinases and akt. Arch. Pharm. Res. 33, 151 (2010). https://doi.org/10.1007/s12272-010-2237-3
  21. Kimura, M., Waki, I., Tanaka, O., Nagai, Y. and Shibata, S. : Pharmacological sequential trials for the fractionation of components with hypoglycemic activity in alloxan diabetic mice from ginseng radix. J. Pharmacobiodyn. 4, 402 (1981). https://doi.org/10.1248/bpb1978.4.402
  22. Shezard, O., Ha, I. J., Park, Y., Ha, Y. W. and Kim, Y. S. : Development of a rapid and convenient method to separate eight ginsenosides from Panax ginseng by high-speed countercurrent chromatography coupled with evaporatative light scattering detection. J. Separation Sci. 34, 1116 (2011). https://doi.org/10.1002/jssc.201000932
  23. Lin, M., Yin, N., Murphy, B., Medof, M. E., Segerer, S., Heeger, P. S. and Schroppel, B. : Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes. 59, 2247 (2010). https://doi.org/10.2337/db10-0044
  24. Ventura-Sobrevilla, J., Boone-Villa, V. D., Aguilar, C. N., Roman-Ramos, R., Vega-Avila, E., Campos-Sepulveda, E. and Alarcon-Aguilar, F. : Effect of varying dose and administration of streptozotocin on blood sugar in male CD1 mice. Proc. West. Pharmacol. Soc. 54, 5 (2011).
  25. Xie, J. T., Mehendale, S. R., Wang, A., Han, A. H., Wu, J. A., Osinski, J. and Yuan, C. S. : American ginseng leaf: ginsenoside analysis and hypoglycemic activity. Pharmacol. Res. 49, 113 (2004). https://doi.org/10.1016/j.phrs.2003.07.015
  26. Ogawa, M., Maruyama, T., Hasegawa, T., et al. : The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetes (NOD) mice. Biomed. Res. 6, 103 (1985). https://doi.org/10.2220/biomedres.6.103
  27. Christianson, S. W., Shultz, L. D. and Leiter, E. H. : Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes. 24, 44 (1993).
  28. Makoto Miyara, Guy Gorochov, Michael Ehrenstein, Lucile Musset, Shimon Sakaguchi and Zahir Amoura : Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmunity Reviews 10, 744 (2011). https://doi.org/10.1016/j.autrev.2011.05.004
  29. Joo, I., Kim, H., Kim, J., Lee, J. Y., Omer, S., Kim, Y. S. and Han, Y. : Immunoadjuvant effects of ginsenosides Rd and Rg1 Yakhak Hoeji (2012). (submitted).
  30. Choy, E. H., Kingsley, G. H. and Panayi, G. S. : Monoclonal antibody therapy in rheumatoid arthritis. Br. J. Rheumatol. 37, 484 (1998). https://doi.org/10.1093/rheumatology/37.5.484